PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25724183-4 2015 Further, cinobufotalin inhibited sphingosine kinase 1 (SphK1) activity and induced pro-apoptotic ceramide production. cinobufotalin 9-22 sphingosine kinase 1 Homo sapiens 33-53 25724183-4 2015 Further, cinobufotalin inhibited sphingosine kinase 1 (SphK1) activity and induced pro-apoptotic ceramide production. cinobufotalin 9-22 sphingosine kinase 1 Homo sapiens 55-60 25724183-5 2015 Ceramide synthase-1 small hairpin RNA (shRNA)-depletion inhibited cinobufotalin-induced ceramide production and HCC cell apoptosis. cinobufotalin 66-79 ceramide synthase 1 Homo sapiens 0-19 25724183-5 2015 Ceramide synthase-1 small hairpin RNA (shRNA)-depletion inhibited cinobufotalin-induced ceramide production and HCC cell apoptosis. Ceramides 88-96 ceramide synthase 1 Homo sapiens 0-19 25724183-6 2015 On the other hand, the glucosylceramide synthase (GCS) inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitated cinobufotalin-induced ceramide production and cell apoptosis. RV 538 65-113 UDP-glucose ceramide glucosyltransferase Homo sapiens 23-48 25724183-6 2015 On the other hand, the glucosylceramide synthase (GCS) inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitated cinobufotalin-induced ceramide production and cell apoptosis. RV 538 65-113 UDP-glucose ceramide glucosyltransferase Homo sapiens 50-53 25724183-6 2015 On the other hand, the glucosylceramide synthase (GCS) inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitated cinobufotalin-induced ceramide production and cell apoptosis. RV 538 115-119 UDP-glucose ceramide glucosyltransferase Homo sapiens 23-48 25724183-6 2015 On the other hand, the glucosylceramide synthase (GCS) inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitated cinobufotalin-induced ceramide production and cell apoptosis. RV 538 115-119 UDP-glucose ceramide glucosyltransferase Homo sapiens 50-53 25724183-6 2015 On the other hand, the glucosylceramide synthase (GCS) inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitated cinobufotalin-induced ceramide production and cell apoptosis. cinobufotalin 133-146 UDP-glucose ceramide glucosyltransferase Homo sapiens 23-48 25724183-6 2015 On the other hand, the glucosylceramide synthase (GCS) inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitated cinobufotalin-induced ceramide production and cell apoptosis. cinobufotalin 133-146 UDP-glucose ceramide glucosyltransferase Homo sapiens 50-53 25724183-6 2015 On the other hand, the glucosylceramide synthase (GCS) inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitated cinobufotalin-induced ceramide production and cell apoptosis. Ceramides 31-39 UDP-glucose ceramide glucosyltransferase Homo sapiens 50-53 25724183-7 2015 SphK1 inhibitor II (SKI-II), similar to cinobufotalin, increased cellular ceramide level and promoted HCC cell apoptosis. Ceramides 74-82 sphingosine kinase 1 Homo sapiens 0-5 25724183-8 2015 Finally, we observed that cinobufotalin inactivated Akt-S6K1 signaling in HepG2 cells, which was again inhibited by ceramide synthase-1 shRNA-depletion. cinobufotalin 26-39 ceramide synthase 1 Homo sapiens 116-135